全文获取类型
收费全文 | 4841篇 |
免费 | 261篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 208篇 |
妇产科学 | 85篇 |
基础医学 | 467篇 |
口腔科学 | 65篇 |
临床医学 | 532篇 |
内科学 | 971篇 |
皮肤病学 | 44篇 |
神经病学 | 526篇 |
特种医学 | 579篇 |
外科学 | 491篇 |
综合类 | 77篇 |
一般理论 | 5篇 |
预防医学 | 279篇 |
眼科学 | 288篇 |
药学 | 280篇 |
中国医学 | 5篇 |
肿瘤学 | 195篇 |
出版年
2022年 | 31篇 |
2021年 | 56篇 |
2020年 | 40篇 |
2019年 | 37篇 |
2018年 | 65篇 |
2017年 | 54篇 |
2016年 | 69篇 |
2015年 | 79篇 |
2014年 | 104篇 |
2013年 | 181篇 |
2012年 | 166篇 |
2011年 | 182篇 |
2010年 | 165篇 |
2009年 | 139篇 |
2008年 | 162篇 |
2007年 | 158篇 |
2006年 | 169篇 |
2005年 | 144篇 |
2004年 | 113篇 |
2003年 | 137篇 |
2002年 | 147篇 |
2001年 | 116篇 |
2000年 | 144篇 |
1999年 | 113篇 |
1998年 | 160篇 |
1997年 | 147篇 |
1996年 | 145篇 |
1995年 | 114篇 |
1994年 | 96篇 |
1993年 | 96篇 |
1992年 | 95篇 |
1991年 | 70篇 |
1990年 | 64篇 |
1989年 | 108篇 |
1988年 | 88篇 |
1987年 | 97篇 |
1986年 | 103篇 |
1985年 | 101篇 |
1984年 | 67篇 |
1983年 | 70篇 |
1982年 | 55篇 |
1981年 | 35篇 |
1980年 | 56篇 |
1979年 | 55篇 |
1978年 | 36篇 |
1977年 | 32篇 |
1976年 | 34篇 |
1975年 | 47篇 |
1935年 | 22篇 |
1933年 | 26篇 |
排序方式: 共有5130条查询结果,搜索用时 15 毫秒
1.
2.
M C Post J G L M Luermans H W M Plokker W Budts 《Catheterization and cardiovascular interventions》2007,69(1):9-14
Migraine is a common neurological disorder with a great impact on the quality of life and social activities. The patent foramen ovale (PFO) is an intra-atrial right-to-left shunt with a prevalence of 25% in the general population. An increased prevalence is found in patients with migraine, especially in migraine with aura. Percutaneous PFO closure might decrease the prevalence of migraine. However, most of these observational studies were retrospective without a randomized design and the results need to be interpreted with caution. In this review we describe the association between PFO and migraine and the different pathophysiological hypotheses, which have been proposed to explain this relationship. 相似文献
3.
JA HYEON KU CHEOL KWAK SEUNG-JUNE OH EUNSIK LEE SANG EUN LEE JAE-SEUNG PAICK 《International journal of urology》2004,11(7):489-493
BACKGROUND: Our aims in the present study were to estimate the influences of pain and urinary symptoms on quality of life, and to determine which of these two variables has the most predictive power with respect to quality of life in young men with chronic prostatitis-like symptoms. METHODS: Chronic prostatitis-like symptoms were measured by the National Institutes of Health-Chronic Prostatitis Symptom Index. Of the 28,841 men aged 20 years who lived in the study community, 18,495 men (a response rate 64.1%) agreed to participate in the study. A total of 1057 men who complained of symptoms indicative of chronic prostatitis were included in the study. The influences of pain and urinary symptoms on quality of life were determined using logistic regression analysis. The receiver operating characteristic (ROC) curve was used to estimate the predictive ability of each of these variables with respect to quality of life. RESULTS: Results from multivariate analysis showed that both pain and urinary symptoms were associated with an increased likelihood of impaired quality of life, although pain contributed more to a reduced quality of life than urinary symptoms. Relative to men who experienced mild pain, men who experienced moderate pain had a 3.9-fold risk of poor quality of life (odds ratio [OR], 3.87; 95% confidence interval [CI], 2.86-5.23; P < 0.001) and those who experienced severe pain had a 15.7-fold risk of reduced quality of life (OR, 15.68; 95% CI, 6.59-37.35; P < 0.001). Moderate urinary symptoms were associated with a 1.4-fold risk of bother (OR, 1.41; 95% CI, 1.01-1.99; P < 0.001) and severe urinary symptoms were associated with 2.4-fold risk (OR, 2.39; 95% CI, 1.37-4.12; P < 0.001), relative to mild urinary symptoms. Comparison of the effects of pain and urinary symptoms showed that pain severity had the most predictive power for bother, quality of life, and quality-of-life impact. The areas under the ROC curves for bother, quality of life, and quality-of-life impact were 71.3%, 69.3% and 72.5%, respectively. CONCLUSION: Urinary symptoms and pain might be associated with an increased likelihood of impaired quality of life in young men with chronic prostatitis-like symptoms. In addition, our findings suggest that pain severity is the most influential variable for determining quality of life in this population. 相似文献
4.
A new method is presented for studying mediator release in isolated peritoneal cells of the rat. Using a superfusion technique, cells can be maintained in a continuously cleared medium. Cells were stimulated with antigen, compound 48/80 or A23187 to characterize this preparation. In addition, inhibitory effects of theophylline, isoprenaline and cromoglycate on compound 48/80-induced histamine release were studied. We conclude that superfusion is a valid alternative to study mediator release from isolated peritoneal cells. 相似文献
5.
6.
7.
Organic nitrates are used for the treatment of angina pectoris symptoms, acute coronary syndrome and for acute and chronic heart insufficiency. In spite of the proven effectiveness of organic nitrates for acute cases, long-term therapy is limited by to the development of tolerance. Recent animal experiments, as well as clinical data, show that an endothelial dysfunction is also induced, a disquieting point, especially considering the negative prognostic impact of endothelial dysfunction. Due to these side effects, the published guidelines of the American Heart Association and the American College of Physicians do not recommend the use of long-term nitrates, such as mono- and dinitrate, for the treatment of stable angina pectoris. Rather, if good left ventricular function is present the calcium antagonist amlodipine should be used. In cases of appreciably reduced left ventricular function, there is a current discussion, based on the recently published A-HeFT study, as to whether a combination therapy with organic nitrates and the effective arteriole dilator hydralazine is beneficial for patients with severe heart insufficiency. 相似文献
8.
Lawrence T. Post 《American journal of ophthalmology》1943,26(6):629-631
9.
10.